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IntroductIon
Obesity, a risk factor for several common diseases, reflects 
an imbalance in energy intake and energy expenditure (1). 
Although environmental factors play an important role in 
the development of obesity, the heritability of BMI has been 
shown to be as high as 80% (2). Recent large-scale genome-
wide association studies have identified various genetic vari-
ants that are unequivocally associated with obesity-related 
traits (3–13). Of these loci, the genetic variation in FTO (fat 
mass and obesity associated) was the firstly discovered locus 
which has still the largest, yet small, effect on obesity suscep-
tibility to date (3–6). Each FTO risk allele increases BMI by 
0.26–0.66 kg·m–2, equivalent to ~0.84–2.1 kg in body weight 
for a person of 1.80-m tall, and the risk of obesity by 1.25–1.32 
odds (14).
Many studies (15,16), although not all (17,18), have shown 
that the BMI-increasing effect of the FTO variant is stronger 
in physically inactive individuals than in active individuals. 
It is however not known whether this attenuation is due to a 
healthy lifestyle in general, for example involving a particular 
association Between FTO Variant and Change 
in Body Weight and Its Interaction With  
Dietary Factors: the DiOgenes study
Karani S. Vimaleswaran1, Lars Ängquist2, Rikke D. Hansen3, Daphne L. van der A4,  
Nabila Bouatia- Naji1,5,6, Claus Holst2, Anne Tjønneland3, Kim Overvad7,8, Marianne U. Jakobsen8, 
Heiner Boeing9, Karina Meidtner9, Domenico Palli10, Giovanna Masala10, Wim H.M. Saris11,  
Edith J.M. Feskens12, Nicholas J. Wareham1, Thorkild I.A. Sørensen2 and Ruth J.F. Loos1
Although FTO is an established obesity-susceptibility locus, it remains unknown whether it influences weight  
change in adult life and whether diet attenuates this association. Therefore, we investigated the association of 
FTO-rs9939609 with changes in weight and waist circumference (WC) during 6.8 years follow-up in a large-scale 
prospective study and examined whether these associations were modified by dietary energy percentage from fat, 
protein, carbohydrate, or glycemic index (GI). This study comprised data from five countries of European Prospective 
Investigation into Cancer and Nutrition (EPIC) and was designed as a case-cohort study for weight gain. Analyses 
included 11,091 individuals, of whom 5,584 were cases (age (SD), 47.6 (7.5) years), defined as those with the greatest 
unexplained annual weight gain during follow-up and 5,507 were noncases (48.0 (7.3) years), who were compared in 
our case-noncase (CNC) analyses. Furthermore, 6,566 individuals (47.9 (7.3) years) selected from the total sample  
(all noncases and 1,059 cases) formed the random subcohort (RSC), used for continuous trait analyses. Interactions 
were tested by including interaction terms in the models. In the RSC-analyses, FTO-rs9939609 was associated 
with BMI (β (SE), 0.17 (0.08) kg·m−2/allele; P = 0.034) and WC (0.47 (0.21) cm/allele; P = 0.026) at baseline, but not 
with weight change (5.55 (12.5) g·year–1/allele; P = 0.66) during follow up. In the CNC-analysis, FTO-rs9939609 was 
associated with increased risk of being a weight-gainer (OR: 1.1; P = 0.045). We observed no interaction between  
FTO-rs9939609 and dietary fat, protein and carbohydrate, and GI on BMI and WC at baseline or on change in weight 
and WC. FTO-rs9939609 is associated with BMI and WC at baseline, but association with weight gain is weak and  
only observed for extreme gain. Dietary factors did not influence the associations.
Obesity (2012) 20, 1669–1674. doi:10.1038/oby.2012.49
1MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge, UK; 2Institute of Preventive Medicine, Copenhagen University Hospital, Copenhagen, Denmark; 
3Danish Cancer Society Research Center, Unit of Diet, Genes and Environment, Copenhagen, Denmark; 4National Institute for Public Health and the Environment 
(RIVM), Bilthoven, The Netherlands; 5University Lille Nord de France, Lille, France; 6CNRS, UMR8199, Department of Genomics of Metabolic Diseases, Institut 
Pasteur de Lille, Lille, France; 7Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 8Department of Clinical Epidemiology, 
Aarhus University Hospital, Aalborg, Denmark; 9Department of Epidemiology, GermanInstitute of Human Nutrition, Potsdam, Germany; 10Molecular and Nutritional 
Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy; 11Department of Human Biology, Nutrition and Toxicology Research Institute of 
Maastricht (NUTRIM), Maastricht, The Netherlands; 12Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands. Correspondence: Ruth J.F. 
Loos (ruth.loos@mrc-epid.cam.ac.uk)
Received 6 April 2011; accepted 12 February 2012; advance online publication 15 March 2012. doi:10.1038/oby.2012.49
articles
Genetics
1670 VOLUME 20 NUMBER 8 | aUgUst 2012 | www.obesityjournal.org
dietary composition, or whether it is due to effects that are spe-
cific to physical activity.
In the present study, we examine the association of the FTO-
rs9939609 variant with BMI and WC at baseline and also 
change in weight and WC over an average period of 6.8 (SD 2.5) 
years. We furthermore test whether associations are modified 
by fat E%, carbohydrate E%, protein E%, and glycemic index 
(GI). We tested our hypotheses in a large prospective popula-
tion which comprises data from five European countries (n = 
11,091) participating in the European Prospective Investigation 
into Cancer and Nutrition (EPIC).
Methods and Procedures
study population
The study is part of the DiOGenes project (http://www.diogenes-eu.
org/), a multidisciplinary European programme that focuses on dietary 
components and genetic and behavioural factors in the prevention of 
weight gain (19). The current analyses include data from five countries 
participating in the EPIC (19); i.e., Denmark (Aarhus and Copenhagen), 
Germany (Potsdam), United Kingdom (Norfolk), Italy (Florence), 
and the Netherlands (Doetinchem, Amsterdam, and Maastricht) (see 
Supplementary Table S1 online). Individuals younger than 60 years at 
baseline and younger than 65 years at follow-up, with stable smoking 
habits, without cancer, cardiovascular disease, or diabetes at baseline 
and at follow-up, and with an annual weight change not >5 kg/year were 
eligible for the current study. In total, 50,293 men and women (22,844 
participants from Denmark, 6,446 from the UK, 8,813 from Germany, 
6,576 from the Netherlands, and 5,614 from Italy) for whom baseline 
information for BMI, weight, height, and diet, and follow-up informa-
tion on weight were available, were eligible for inclusion in our analyses 
(see Supplementary Table S2 online).
study design
The study design has been described in detail before (20). In brief, 
cases were defined as those individuals who had experienced the great-
est degree of unexplained weight gain and were identified by using the 
residuals from a regression model of annual weight change on base-
line values of age, weight, height, and smoking status (current/former/
nonsmokers) and follow-up time. In each of the countries except Italy, 
cases were identified as the 600 men and 600 women with the largest 
unexplained weight gain. As men were underrepresented (27%) in the 
Italian cohort, 300 men and 900 women were selected to represent the 
sex distribution of this cohort.
Noncases together with some cases formed the random subcohort 
(RSC). The random sample subcohort comprised a random sample of 
individuals that was drawn in such a way that the total number of non-
cases (controls) in each centre equaled the number of cases (n = 1,200) 
(see Supplementary Table S2 online). To obtain in total 6,000 noncases, 
over sampling was performed in all centers except Denmark, where over-
lap between cases and subcohort was negligible (n = 79). In total, 7,063 
participants were included in the RSC, of which 5,930 were noncases.
Of the 11,930 participants, 11,257 had DNA available for genotyp-
ing. Of these, genotyping failed for 143 samples and for 23 individuals, 
nutritional data was not available. Hence, our analyses included 11,091 
individuals of whom, 5,584 were cases (weight-gainers) and 5,507 were 
noncases. For the case-noncase (CNC) analysis, 5,584 cases and 5,507 
noncases were used. The RSC (n = 6,566) consisted of the 5,507 noncases 
(controls) and 1,059 cases.
anthropometry, dietary, and other measurements
Details of the anthropometric measurements have been described 
previously (21). In brief, at baseline all participants were measured for 
weight, height, and waist circumference (WC) using standard study 
protocols. At follow-up, participants in Norfolk (UK) and Doetinchem 
(NL) were measured by trained technicians, whereas participants of the 
other cohorts measured their weight and WC at home according to the 
guidance provided. The mean follow-up period was 6.8 ± 2.5 (mean ± 
SD) years.
Information on lifestyle was collected via self-administered question-
naires at baseline. Validated country-specific Food Frequency Question-
naires were used to collect dietary information at baseline (22). Energy 
and nutrient intake were calculated using country-specific food composi-
tion tables and subsequently calibrated using 24-h recall data collected 
from a random sample of all EPIC participants (23). Energy and nutri-
ent intake from 24-h recalls were calculated based on the standardized 
European Nutrient DataBase (24). The values of absolute intakes of fat, 
protein, and carbohydrate are transformed to energy-form by multiplying 
with macronutrient-specific factor, dividing by total energy, and finally 
multiplying by 100 in order to get values to percentage (0–100) form. 
This was used for calculating fat E%, protein E%, and carbohydrate E%. 
A specifically developed GI database was used to calculate dietary GI; 
the methodologies for their calculation have been described in detail 
elsewhere (25,26).
dna extraction and genotyping
Genomic DNA was extracted from the buffy coats with a salting out 
method for all participants except for samples from the UK for which 
whole-genome amplified DNA was used. The FTO variant (rs9939609) 
was genotyped using the Illumina Beadstation Genotyping System. 
Researchers and laboratory personnel were blinded to case status and 
phenotypic data of the samples. The concordance rate and reproducibil-
ity were 100% and genotyping call rate was >98%. Genotype distribu-
tion in the RSC was in accordance with Hardy–Weinberg equilibrium 
in each of the cohorts (see Supplementary Table S3 online).
statistical analysis
The association between the FTO-rs9939609 variant and continuous 
traits (i.e., baseline BMI, baseline WC, weight change and change in 
WC) was examined in the RSC only, using linear regression analyses. 
The association between rs9939609 and the risk of being a case (weight 
gainer) was tested using logistic regression comparing cases versus 
noncases. All association analyses assumed an additive effect of the 
minor allele and were adjusted for the baseline values of age, weight, 
and sex. The association analyses for weight gain were adjusted for age, 
sex, baseline weight and height. Weight gain was expressed in g/year.
Interactions between the SNP and the dietary factors (fat E%, 
 carbohydrate E%, protein E%, and GI) were tested by adding the inter-
action terms in the regression models. We also tested whether association 
and interaction were different across age and between men and women 
by including the respective interaction terms in the models.
As the genotype distribution of the variant rs9939609 (P = 0.012) (see 
Supplementary Table S3 online) and some phenotypic  characteristics 
differed across the five countries, analyses were first conducted in each 
study center separately and subsequently meta-analyzed using a  random 
effects model. This approach accounts for the possible heterogene-
ity across study centers and results in an overall (weighted) estimate. 
 Heterogeneity was tested using the Cochran Q-test and I2.
Statistical analysis was conducted using SAS 9.1 for windows (SAS 
Institute, Cary, NC) and STATA 9.2 for Windows (StataCorp LP, College 
Station, TX). Power calculations were performed using Quanto v1.1.1 
(http://hydra.usc.edu/gxe). The statistical power to detect an effect size 
of 0.36 kg/m2 as reported by Willer et al. (4) at a significance level of 5% 
was 99.99%. At 80% power, we were able to detect an effect size of at least 
0.18 kg/m2 for a minor allele frequency of 0.41 and a sample size of 6,566 
individuals. For gene–diet interactions, the least detectable effect sizes 
for annual weight gain and CNC status corresponding to 80% power and 
significance level 0.05 are 6.2 g/year and 1.012 odds per gene-diet unit 
respectively for carbohydrates (carbohydrates%), 7.2 g/year, and 1.014 
odds per gene-diet unit respectively for fat (fat%), 15.9 g/year, and 1.031 
odds per gene-diet unit respectively for protein (protein%) and 11.7 g/ year 
and 1.023 odds per gene-diet unit respectively for GI  (GI-unit). For ease 
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of interpretation, an effect size of 6.2 g/year and 1.012 odds in a gene–
diet interaction analysis means that the association between the FTO 
variant and weight gain is more pronounced in individuals with a higher 
carbohydrate energy percentage. More specifically, with every energy 
percentage increase in dietary carbohydrate, the association between the 
FTO variant and weight gain increases by 6.2 g/year and with the risk of 
being a weight-gainer increases by 1.012 odds.
results
The FTO-rs9939609 A-allele was associated with higher BMI 
(β (SE), 0.17 (0.08) kg·m–2/allele; P = 0.034) (Figure 1) and 
WC (β (SE), 0.47 (0.21) cm/allele; P = 0.026) in the RSC. 
Heterogeneity across the study centres was low to modest 
with effect sizes ranging from –0.08 kg·m–2/allele (in The 
Netherlands—Amsterdam & Maastricht) to 0.43 kg·m–2/
allele (in Denmark) for BMI (heterogeneity I2 = 37.1%) and 
from –0.21 cm/allele (in The Netherlands—Amsterdam 
& Maastricht) to 1.04 cm/allele (in Denmark) for WC 
(I2 = 37 %).
In the analyses of the RSC, we observed no association between 
the FTO-rs9939609 variant and changes in weight (β (SE), 5.34 
(12.5) g·year–1/allele; P = 0.66) or in WC (β (SE), –0.004 (0.02) 
cm·year–1/allele; P = 0.81). We observed no heterogeneity across 
study centres; the effect sizes ranged from –18.01 g·year–1/allele 
(in The Netherlands—Amsterdam & Maastricht) to 87.25 
g·year–1/allele (in The Netherlands—Doetinchem) for weight 
change (heterogeneity, I2 = 0.9%) (Figure 2) and ranged from 
–0.04 cm·year–1/allele (in Italy-Florence) to 0.09 cm·year–1/allele 
(in Denmark-Copenhagen and Aarhus) for change in WC.
The CNC comparison showed that the rs9939609 A-allele was 
associated with a 1.06-fold increased odds of being a weight-
gainer (95% CI: 1.00–1.11; P = 0.045) (Figure 3). The odds 
ratios across the study centres ranged from 1.01 (in Germany 
and Denmark) to 1.18 (in The Netherlands—Doetinchem) for 
weight change (heterogeneity, I2 = 0 %).
We observed no interactions between the rs9939609 vari-
ant and fat E%, protein E%, carbohydrate E%, or GI on any 
of BMI, WC, changes in weight or WC, and on risk of being a 
case (Table 1). Furthermore, there was no evidence for interac-
tion of the variant with sex and age (sex: Pinteraction = 0.65; age: 
Pinteraction = 0.40) on BMI and WC at baseline and also change 
in weight and WC.
dIscussIon
In this prospective study of 11,091 adults of five Europeans 
countries, we confirmed association of the FTO-rs9939609 
variant with BMI and WC at baseline. However, no associations 
between this FTO variant and changes in weight or WC during 
6.8 years of follow-up in adult life were observed. Furthermore, 
fat E%, carbohydrate E%, protein E%, and GI did not affect the 
associations of the FTO variant with baseline BMI, WC or with 
changes in weight or WC.
The overall effect of rs9939609 variant on BMI and WC is 
comparatively smaller in our study than the effect sizes shown 
in other studies, where each FTO risk allele has been shown to 
increase BMI by ~0.40–0.66 kg·m–2 (4) and WC by ~1.0–2.4 cm 
(27). When we stratified by study centre, the effect sizes in the 
present study ranged from –0.08 kg·m–2/allele to 0.43 kg·m–2/
allele for BMI and from –0.21 cm/allele to 1.04 cm/allele for 
WC. Although our populations are not markedly different in 
terms of average BMI, age, or sex-ratio from those reported 
on in the past, even the upper range of effect sizes observed in 
the participating centres of our study only reached the lower 
range of those observed in previously published studies. It is 
not clear why we observed smaller average effect sizes, but this 
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Figure 1 Association of the FTO variant, rs9939609, with baseline BMI (kg/m2) (random subcohort analysis) in the DiOGenes study. The analyses 
were first conducted in each study center and random-effect meta-analyses were used to pool the estimates and evaluate heterogeneity (I2). 95% CI, 
95% confidence interval.
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is not necessarily affecting the chances of finding interactions 
between the gene variant and dietary factors.
Furthermore, we observed no association between the FTO 
variant and change in weight or in WC. However, we found 
a trend for the rs9939609 A-allele to be associated with 1.06-
fold increased odds of being a weight-gainer (P = 0.045), which 
suggests that FTO’s effect on weight gain is only observed in 
extreme weight-gainers, at least in adults. Two recent stud-
ies showed that the FTO locus is associated with weight gain 
during childhood and adolescence, while the effect attenu-
ates during adult life (28,29). A case-cohort study in 1,629 
Danish men, representing a broad range of BMI, showed that 
the AA genotype of the FTO variant, rs9939609, was signifi-
cantly associated with weight gain from birth to the age of 
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OR for risk of being a “weight gainer” per minor allele
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Figure 3 Association of the FTO variant, rs9939609, with risk of being a weight-gainer (case-noncase analysis) in the DiOGenes study. The analyses 
were first conducted in each study center and random-effect meta-analyses were used to pool the estimates and evaluate heterogeneity (I2). 95% CI, 
95% confidence interval.
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Figure 2 Association of the FTO variant, rs9939609, with weight change (g/year) (Random subcohort analysis) in the DiOGenes study. The analyses 
were first conducted in each study center and random-effect meta-analyses were used to pool the estimates and evaluate heterogeneity (I2). 95% CI, 
95% confidence interval.
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7 years (P  = 0.001) but was not associated with further weight 
gain during childhood and adolescence (28). A study in 1,240 
men and 1,239 women from the MRC National Survey of 
Health and Development showed that the association between 
FTO variant, rs9939609, and BMI strengthened during child-
hood and adolescence, reached a peak strength at age 20 years, 
and then weakened during adulthood (29). Furthermore, two 
studies (18,30), one in 1,275 Dutch adolescents and the other in 
1,592 Europeans and African–Americans, failed to observe the 
changes in effect of the variant on adiposity measures across 
childhood and adolescence. These studies suggest that the dif-
ference in BMI and body weight between the three genotypes 
are established early in life and subsequently track into adult-
hood, which is consistent with our observations of a somewhat 
weaker association.
A few studies have examined the interaction between the 
FTO variant and dietary intake on obesity traits. A study 
in 204 German individuals found that the FTO-rs8050136 
(r2  = 1.0, with the SNP rs9939609) was associated with BMI 
at baseline (P < 0.0001), but not with change in body weight 
after a 9-month lifestyle (exercise and dietary intervention) 
intervention programme (P = 0.95 for intervention vs. gen-
otype effect) (31). Furthermore, a study in 776 individuals 
with a high cardiovascular risk observed no significant inter-
action between the nutritional intervention (followed-up 
for 3 years) and the FTO SNP rs9939609 on changes in the 
body weight (32). However, a cross-sectional study in 4,839 
individuals from the population-based Malmö Diet and 
Cancer study (33) showed significant interactions between 
the FTO SNP rs9939609 and fat (P = 0.04) and carbohydrate 
(P = 0.001) intakes on BMI. Also, a recent study in 21,675 
healthy Caucasian women showed that lifestyle factors modi-
fied the genetic risk of FTO on obesity phenotypes among 
those who were both inactive and had high intake of calories 
(34). The lack of interaction in some of the studies could be 
due to the small sample size (n < 2,500) and short follow-up 
periods or inaccurate measurement of dietary information, 
which might reduce the statistical power to identify inter-
actions. Despite the fact that our study is large and has suf-
ficient power to identify small changes, we did not observe 
interaction between the FTO variant and fat E%, protein E%, 
carbohydrate E%, and GI on weight change. While previous 
studies found that the BMI-increasing effect is modified by 
physical activity (15,16,27), our study suggests that the com-
position of the food with regard to fat, protein, carbohydrate 
and GI does not have this effect. Our observations and those 
of others suggest that living a healthy lifestyle in general is 
not sufficient to attenuate the effect, but that the attenuation 
may be specific to physical activity.
A few studies have examined the influence of dietary fac-
tors on FTO gene function at the molecular level. The FTO 
variant rs8050136 (r2 = 1.0, with the SNP rs9939609) affects 
binding affinity of the transcription factor, CUX1, which 
regulates the FTO gene expression (35). Reduced expression 
of Fto was shown to affect leptin signaling in vitro. Studies 
have also shown that excess fat intake (36) and high-protein 
diets (37) may influence the serum levels of leptin. It may be 
hypothesized that excess fat and protein intake might have 
an effect on the binding affinity of CUX1, which can affect 
FTO expression and, in turn, affect leptin signaling leading 
to obesity. However, further studies are required to prove this 
hypothesis.
In summary, our study confirms that genetic variation in 
FTO is associated with the general level of fatness as assessed 
by BMI and WC. However, the evidence of association with 
weight change during adult life is weak and association was 
only observed for more extreme weight gain. The results sug-
gest that weight changes in adults are not influenced by inter-
actions between the FTO polymorphism and macronutrient 
composition of the diet.
table 1 Main effects and the interaction P values for the FTO variant, rs9939609 in the random subcohort and case-noncase 
analyses of the study participants from the dioGenes study
Main effects
Heterogeneity, 
I2
Interactions
β ± SE P value
P value 
for FTO × 
protein %
P value for 
FTO × fat %
P value for FTO × 
carbohydrate %
P value 
for FTO × 
glycemic 
index
Random subcohort analysis
Baseline BMI (kg·m–2/allele) 0.17 ± 0.08 0.034 37% 0.88 0.45 0.70 0.52
Baseline WC (cm/allele) 0.47 ± 0.21 0.026 37% 0.41 0.32 0.67 0.60
Weight change (g·year–1/allele) 5.55 ± 12.5 0.66  8% 0.10 0.82 0.37 0.99
Waist change (cm·year–1/allele) –0.004 ± 0.02 0.81  0% 0.37 0.67 0.58 0.36
Case-noncase analysis
Odd ratio  
(95% CI)
P value Heterogeneity, 
I2
P value 
for FTO × 
protein %
P value for 
FTO × fat %
P value for FTO × 
carbohydrate %
P value 
for FTO × 
glycemic 
index
Risk of being a weight gainer 1.06 (1.00–1.11) 0.045  0% 0.24 0.95 0.71 0.99
95% CI, 95% confidence interval; WC, waist circumference.
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